Chordin anticorps
-
- Antigène Voir toutes Chordin (CHRD) Anticorps
- Chordin (CHRD)
- Reactivité
- Humain, Souris, Rat
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp Chordin est non-conjugé
-
Application
- Immunohistochemistry (IHC), ELISA
- Attributs du produit
- Polyclonal Antibody
- Purification
- Antigen affinity purification
- Immunogène
- Fusion protein of human CHRD
- Isotype
- IgG
- Top Product
- Discover our top product CHRD Anticorps primaire
-
-
- Indications d'application
- IHC 1:30-1:150, ELISA 1:5000-1:10000
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 0.8 mg/mL
- Buffer
- PBS with 0.05 % Sodium azide and 40 % Glycerol, pH 7.4
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C
- Stockage commentaire
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Antigène
- Chordin (CHRD)
- Autre désignation
- CHRD (CHRD Produits)
- Synonymes
- anticorps chd, anticorps X-chordin, anticorps Chd, anticorps chordino, anticorps wu:fe47d04, anticorps chordin, anticorps chordin, gene 1, anticorps chordin, gene 1 S homeolog, anticorps CHRD, anticorps chrd.1, anticorps LOC778563, anticorps Chrd, anticorps chrd, anticorps chrd.1.S
- Sujet
- CHRD (Chordin) is a Protein Coding gene. Diseases associated with CHRD include Cornelia De Lange Syndrome. Among its related pathways are Mesodermal Commitment Pathway and TGF-beta signaling pathway (KEGG). GO annotations related to this gene include heparin binding and syndecan binding. An important paralog of this gene is CHRDL2.This gene encodes a secreted protein that dorsalizes early vertebrate embryonic tissues by binding to ventralizing TGF-beta-like bone morphogenetic proteins and sequestering them in latent complexes. The encoded protein may also have roles in organogenesis and during adulthood. It has been suggested that this gene could be a candidate gene for Cornelia de Lange syndrome. Reduced expression of this gene results in enhanced bone regeneration. Alternative splicing results in multiple transcript variants. Other alternative splice variants have been described but their full length sequence has not been determined.
- UniProt
- Q9H2X0
-